SJS Investment Consulting’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
SJS Investment Consulting's ASTH Position: Q3 2026 in Review
SJS Investment Consulting increased its Astrana Health (ASTH) stake by 18% in Q3 2026, buying an estimated $197 and bringing the position to 33 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2430.
SJS Investment Consulting first reported a position in ASTH in Q3 2022 and has held it in 13 quarters since. The position peaked at $1.3K in Q2 2026. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.
- SJS Investment Consulting held 33 shares of Astrana Health worth $1.17K as of Q3 2026.
- SJS Investment Consulting bought 5 Astrana Health shares in Q3 2026, an estimated $197.
- Astrana Health made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2430 holding.
- SJS Investment Consulting first reported a position in Astrana Health in Q3 2022 and has held it in 13 quarters since.
- SJS Investment Consulting's Astrana Health position peaked at $1.3K in Q2 2026.
- 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.